Immune Dysregulation Clinical Trials
2 recruiting trials for Immune Dysregulation. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Immune Dysregulation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Henry M. Jackson Foundation for the Advancement of Military Medicine (1), Université Catholique de Louvain (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Peripheral Blood Collection for Immune Profiling (other, 1 trial).
Track Immune Dysregulation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-cell non-Hodgkin...
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
This study aims to better understand the role of immune system cells in lung diseases such as lung cancer, sarcoidosis, and chronic obstructive pulmonary disease (COPD). The...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Immune Dysregulation, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Immune Dysregulation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Immune Dysregulation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.